Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis

Journal of Clinical Oncology

Volumn 31, Issue 6, 2013, Pages 752-758

  Simon, Thorsten ^a   Haberle, Beate ^b   Hero, Barbara ^a   Von Schweinitz, Dietrich ^b   Berthold, Frank ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD2 ANTIBODY; ISOTRETINOIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; NEUROIMAGING; NEUROSURGERY; OVERALL SURVIVAL; PHYSICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHOOL CHILD; SURGICAL TECHNIQUE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MAINTENANCE CHEMOTHERAPY; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUROBLASTOMA; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; YOUNG ADULT;

EID: 84875740368     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.9339     Document Type: Article

References (26)

1. Matthay KK, Villablanca JG, Seeger RC, et al: Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid: Children's Cancer Group. N Engl J Med 341:1165-1173, 1999 (Pubitemid 29480654)
2. Berthold F, Boos J, Burdach S, et al: Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: A randomised controlled trial. Lancet Oncol 6:649-658, 2005 (Pubitemid 41222755)
3. Pearson AD, Pinkerton CR, Lewis IJ, et al: High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: A randomised trial. Lancet Oncol 9:247-256, 2008 (Pubitemid 351722944)
4. Pritchard J, Cotterill SJ, Germond SM, et al: High dose melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatr Blood Cancer 44:348-357, 2005 (Pubitemid 40316027)
5. McGregor LM, Rao BN, Davidoff AM, et al: The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: The St. Jude Children's Research Hospital Experience. Cancer 104:2837- 2846, 2005 (Pubitemid 41798296)
6. von Schweinitz D, Hero B, Berthold F: The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg 12:402-409, 2002 (Pubitemid 36125447)
7. La Quaglia MP, Kushner BH, Su W, et al: The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 39:412-417, 2004 (Pubitemid 38338359)
8. Castel V, Tovar JA, Costa E, et al: The role of surgery in stage IV neuroblastoma. J Pediatr Surg 37:1574-1578, 2002 (Pubitemid 35253597)
9. Kaneko M, Ohakawa H, Iwakawa M: Is extensive surgery required for treatment of advanced neuroblastomaJ Pediatr Surg 32:1616-1619, 1997 (Pubitemid 27495563)
10. La Quaglia MP, Kushner BH, Heller G, et al: Stage 4 neuroblastoma diagnosed at more than 1 year of age: Gross total resection and clinical outcome. J Pediatr Surg 29:1162-1165, 1994
11. Zwaveling S, Tytgat GA, van der Zee DC, et al: Is complete surgical resection of stage 4 neuroblastoma a prerequisite for optimal survival or may - 95% tumour resection sufficePediatr Surg Int 28:953-959, 2012
12. Cohn SL, Pearson AD, London WB, et al: The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report. J Clin Oncol 27:289-297, 2009
13. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993 (Pubitemid 23228250)
14. Simon T, Hero B, Faldum A, et al: Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy. BMC Cancer 11:21, 2011
15. Simon T, Hero B, Bongartz R, et al: Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children - 1 year with residual local disease. Strahlenther Onkol 182: 389-394, 2006 (Pubitemid 44025006)
16. Cecchetto G, Mosseri V, De Bernardi B, et al: Surgical risk factors in primary surgery for localized neuroblastoma: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 23:8483-8489, 2005
17. Monclair T, Brodeur GM, Ambros PF, et al: The International Neuroblastoma Risk Group (INRG) staging system: An INRG Task Force report. J Clin Oncol 27:298-303, 2009
18. Brisse HJ, McCarville MB, Granata C, et al: Guidelines for imaging and staging of neuroblastic tumors: Consensus report from the International Neuroblastoma Risk Group Project. Radiology 261: 243-257, 2011
19. Collett D: Strategy for Model Selection: Modelling Survival Data in Medical Research. London, United Kingdom, Chapman and Hall, 1994, pp 78-83
20. Koh CC, Sheu JC, Liang DC, et al: Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma. Pediatr Surg Int 21:69-72, 2005
21. Hsu WM, Jen YM, Lee H, et al: The influence of biologic factors on the surgical decision in advanced neuroblastoma. Ann Surg Oncol 13:238-244, 2006 (Pubitemid 43157419)
22. Salim A, Mullassery D, Pizer B, et al: Neuroblastoma: A 20-year experience in a UK regional centre. Pediatr Blood Cancer 57:1254-1260, 2011
23. von Allmen D, Grupp S, Diller L, et al: Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 40:936- 941, 2005 (Pubitemid 40840808)
24. Tsuchida Y, Yokoyama J, Kaneko M, et al: Therapeutic significance of surgery in advanced neuroblastoma: A report from the study group of Japan. J Pediatr Surg 27:616-622, 1992
25. Canete A, Jovani C, Lopez A, et al: Surgical treatment for neuroblastoma: Complications during 15 years' experience. J Pediatr Surg 33:1526-1530, 1998 (Pubitemid 28480915)
26. Shamberger RC, Smith EI, Joshi VV, et al: The risk of nephrectomy during local control in abdominal neuroblastoma. J Pediatr Surg 33:161-164, 1998 (Pubitemid 28093691)